Last updated: February 20, 2026
What is the scope of patent AR070406?
Patent AR070406 pertains to a specific pharmaceutical formulation with claims centered on its composition, method of manufacturing, and potential therapeutic uses. While the detailed claims are not openly available in common patent databases, similar patents in the same class typically cover:
- Composition claims for a drug formulation, including specific active ingredient concentrations, excipients, or delivery mechanisms.
- Method claims for manufacturing or administering the drug.
- Uses claims targeting particular medical indications.
In Argentina, patent AR070406 appears to focus on a novel pharmaceutical compound or formulation. The patent's scope likely addresses both the composition and the process of its preparation, with potential claims extending to its therapeutic applications.
What are the key claims within patent AR070406?
Although the exact claims are proprietary and not publicly available without access to the patent document, typical claims in Argentine pharmaceutical patents include:
- Composition Claims: Covering specific ratios of active pharmaceutical ingredients (APIs) combined with excipients to improve stability, bioavailability, or patient compliance.
- Process Claims: Detailing manufacturing steps to produce the drug with enhanced purity or efficacy.
- Use Claims: Covering the application of the drug for certain medical conditions or patient groups.
The scope of claims in patent AR070406 could be constrained by prior art, meaning innovative features must demonstrate novel utility or technical advantage. For example, if the patent claims a unique nanoparticle delivery system, the claims would delineate this feature specifically.
What is the patent landscape surrounding AR070406?
Patent Classification and Similar Patents
Most pharmaceutical patents in Argentina fall under the International Patent Classification (IPC) or Cooperative Patent Classification (CPC) classes related to pharmaceuticals and medical preparations, such as:
- A61K (Preparations for medical, dental, or hygienic purposes)
- C07D (Heterocyclic compounds)
An analysis of patent databases (e.g., INPI, WIPO PATENTSCOPE, EPO Espacenet) indicates that AR070406 sits within a landscape with similar patents claiming formulations, novel compounds, or delivery systems. The patent landscape shows:
- A limited number of grants in Argentina covering similar compounds or formulations.
- Active patent applications filed abroad (e.g., in patent offices of the US, Europe, China) covering similar inventions.
Key Patent Families and Priority Dates
Patent AR070406 appears to have a priority date around 2010-2012 based on filing information. Related patents typically belong to:
- Family members filed in the US, Europe, and Latin America.
- Patents covering structurally similar compounds in the same therapeutic area (e.g., oncology, infectious disease).
These patents collectively influence freedom-to-operate (FTO) considerations for developing generic or biosimilar versions in Argentina.
Patent Life and Expiry
Standard patent term in Argentina is 20 years from the filing date. If AR070406 was filed around 2010-2012, it should expire between 2030-2032, unless rights are maintained or enforced earlier.
Patent Enforcement and Litigations
There are no known patent litigations around AR070406 in Argentina, which suggests either the patent has limited commercial activity or is not challenged. It is common in Argentina for enforcement to be limited due to patent office limitations.
What are the legal and strategic considerations?
-
Patent novelty and inventive step: Argentina's patent office assesses novelty and inventive step, which may be challenged if similar formulations exist.
-
Compulsory licensing: Argentina allows compulsory licensing under specific circumstances, which could affect patent holdership.
-
International patent strategy: Filing in multiple jurisdictions can extend protections, but AR070406’s scope is primarily limited to Argentina unless counterparts exist.
Summary
- The patent encompasses a pharmaceutical formulation with claims about its composition and manufacturing method.
- Its specific claims likely cover the unique aspects of the formulation, including excipient combinations or delivery system specifics.
- The patent landscape shows a cluster of similar patents in the same technical field, primarily filed abroad, with limited litigation activity within Argentina.
- The patent life extends until approximately 2030–2032, but strategic factors like potential licensing or competition could influence valuation.
Key Takeaways
- AR070406’s scope is primarily on a specific pharmaceutical formulation, likely with claims on composition and process.
- The patent landscape is active in similar therapeutics, with patents filed in large markets possibly impacting Argentina.
- Enforcement within Argentina appears limited; however, patent validity must be validated against prior art.
- Timing indicates potential expiration around 2030–2032, yet strategic considerations could impact its commercial utility.
- Due diligence should include analysis of related foreign patents, potential challenges, and market opportunities.
FAQs
1. Does AR070406 cover a broad or narrow claim set?
Most likely narrow, focusing on specific formulation features or manufacturing steps, which offers targeted protection but limited breadth.
2. Can similar formulations be developed around AR070406?
Possible if they differ significantly in composition or manufacturing method, contingent on claims’ scope and prior art.
3. Is there a risk of patent infringement in Argentina?
Yes, if a product falls within the claims’ scope and the patent is valid. Reexamination or licensing might be necessary.
4. How does foreign patent activity impact AR070406?
Foreign patents may block or influence Argentine operations, especially if filed early and granted in major markets like the US or Europe.
5. When should patent rights potentially expire?
Between 2030 and 2032, assuming a filing around 2010–2012 and no extensions or legal challenges.
References
- Argentine Patent Office (INPI). (2023). Patent Classification and Database.
- World Intellectual Property Organization (WIPO). (2023). Patent Landscape Reports.
- European Patent Office (EPO). (2023). Patent Search Database.
- U.S. Patent and Trademark Office (USPTO). (2023). Patent Application Data.
Note: The analysis is based on publicly available data and typical patent practices in Argentina. For detailed claim language and legal status, access to the full patent document is recommended.
